[Dogs babesiosis--still actually problem]

Area of Science:

• Veterinary Medicine
• Parasitology
• Tick-borne Diseases

Context:

• Babesiosis, also known as piroplasmosis, is a significant tick-borne illness affecting dogs.
• First identified in the United States in 1934, it is caused by protozoa of the Babesia genus.
• In Poland, Babesia canis, transmitted by Dermacentor ticks, is the primary etiological agent.

Purpose:

• To detail the clinical presentation, diagnosis, and therapeutic challenges of canine babesiosis.
• To highlight the diagnostic methods, including microscopy, IF-assay, and PCR.
• To discuss current treatment limitations and potential factors influencing disease severity and therapy effectiveness.

Summary:

• Common symptoms include hemolytic anemia, icterus, and hemoglobinuria, with biochemical and hematological changes such as elevated liver enzymes, bilirubin, urea, creatinine, anemia, leucopenia, and thrombocytopenia.
• Diagnosis relies on anamnesis, clinical examination, blood smear microscopy, IF-assay, and PCR.
• Imidocarb is the most effective drug for canine piroplasmosis, though side effects can occur, and genetic variations may impact treatment outcomes.

Impact:

• Highlights the ongoing difficulties in managing canine babesiosis, particularly regarding effective immunoprophylaxis and treatment.
• Suggests that genetic differences in Babesia subspecies could influence disease progression and therapeutic responses.
• Emphasizes the need for further research into more effective and safer treatment strategies for this widespread canine disease.